Pulmonology Advisor

Ensifentrine May Improve Lung Function in COPD With and Without Exacerbations

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
Pulmonology Advisor

Post-COVID-19, Most Patients With Ongoing Pulmonary Symptoms Have Normal PFTs

Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...
Healio

Roflumilast more beneficial than azithromycin for COPD exacerbations, not mortality

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Inhalers drive carbon emissions equivalent to 530,000 cars each year, study shows

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new ...
aha.org

FY 2026 Updates Part 1: ICD-10-CM Codes and Official Guidelines for Coding and Reporting

Wed, Sep 17, 2025, 12:00 PM CDT – Wed, Sep 17, 2025, 01:00 PM CDT ...
Medical Xpress

IL-10 is a small protein with a big part in preventing pulmonary fibrosis

For a long time, physicians and scientists believed our lungs were sterile (germ-free). But modern science indicates otherwise. Now we know they contain allergens, bacteria or viruses we inhale, such ...
Boston Herald

Merck spends $10 billion for Verona, gaining access to its COPD medication

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. Wall Street rallies to recover some of Friday’s sell-off after ...
The Hill

Merck spends $10 billion for Verona, gaining access to its COPD medication

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new chronic ...